The French Government has extended the age of taking the AstraZeneca vaccine, which was reserved for people between 50 and 64 years old. From now on, people up to 75 years old will also be able to be immunized with this vaccine against covid-19.
“People affected by comorbidities can be vaccinated with the vaccine from AstraZeneca and the University of Oxford, including those aged 65 to 74,” French Health Minister Olivier Véran said on Monday.
According to Newspaper, Pfizer and Moderna vaccines continue to target French citizens over 75 years of age.
The European Medicines Agency approved, at the end of January, the use of the AstraZeneca vaccine for people over 18, without imposing an upper age limit. However, several European countries – including France and Portugal – have recommended its use only in people aged up to 65 years, taking into account the lack of evidence of effectiveness at older ages.
Single dose of Pfizer or AstraZeneca vaccines reduces hospitalization in the elderly
However, a study by British health officials has advanced that a single dose of the Pfizer or AstraZeneca vaccines reduced the chances of people over 80 years of age being hospitalized with covid-19 by more than 80%.
The so-called “real world” study, released this Monday, which is based on data collected from people who have already been immunized in the UK, was produced by Public Health England, public health organization in England.
According to the study, which has not yet been reviewed by independent scientists, since January, protection against symptomatic covid, four weeks after the first dose, varied between 57 and 61% for a dose of the Pfizer vaccine and between 60 and 73% for the AstraZeneca vaccine.
Among those over 80, the data suggest that a single dose of any of the vaccines is more than 80% effective in preventing hospitalization, about three to four weeks after the vaccine, and that the Pfizer vaccine is able to reduce the number of deaths by 83%.
For those over 70 years of age, there are also signs that either vaccine is reduce symptomatic infections about three weeks after the first dose, reinforcing other studies that the vaccines are working and are highly effective in protecting against serious illness, hospitalization and death.
Last week, the Public Health England he had already published a study only on the Pfizer vaccine, which managed to reduce hospitalizations and deaths by more than 75% after the first dose, indicating that vaccines are already having an impact.
“The drop in the rate of hospitalizations is being faster [nos grupos de pessoas mais velhas e vulneráveis] than in young people, who have not yet received vaccines. This is a sign that the vaccine is working. It is very encouraging, ”Said Health Minister Matt Hancock at a press conference.
So far, 20,275,451 people have received the first dose of a vaccine against the new coronavirus in the UK, of which 815,816 have received a second dose, which is administered up to 12 weeks apart.